Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tonini

Showing results (151-160 of 218) with videos related to

Pageof 22
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetronR Gralla, M Lichinitser, S Van Der Vegt, et al.
Minerva Endocrinologica|August 23, 2000
Diagnosis and treatment of hypercortisolism in childrenC De Sanctis, V De Sanctis, G Radetti, et al.
Minerva Pediatrica|December 1, 1996
[Precocious puberty]F Buzi, C De Sanctis, V De Sanctis, et al.
Journal of Endocrinological Investigation|May 9, 2000
GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and DiabetologyA Corrias, J Bellone, L Beccaria, et al.
Histopathology|January 14, 2004
Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancersA M Groeger, V Esposito, A De Luca, et al.
Histopathology|April 22, 2005
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological featuresG Perrone, D Santini, B Vincenzi, et al.
Journal of Clinical Pathology|January 29, 2005
Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinomaD Santini, G Tonini, F M Vecchio, et al.
British Journal of Cancer|October 31, 2008
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?V Catalano, F Graziano, D Santini, et al.
Journal of Clinical Pathology|June 25, 2005
Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancerV Esposito, A Baldi, A De Luca, et al.
European Review for Medical and Pharmacological Sciences|March 7, 2020
Pheromone receptors and their putative ligands: possible role in humansV Precone, S Paolacci, T Beccari, et al.
Pageof 22

Showing results (151-160 of 218) with videos related to

Sort By:
Pageof 22
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetronR Gralla, M Lichinitser, S Van Der Vegt, et al.
Minerva Endocrinologica|August 23, 2000
Diagnosis and treatment of hypercortisolism in childrenC De Sanctis, V De Sanctis, G Radetti, et al.
Minerva Pediatrica|December 1, 1996
[Precocious puberty]F Buzi, C De Sanctis, V De Sanctis, et al.
Journal of Endocrinological Investigation|May 9, 2000
GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and DiabetologyA Corrias, J Bellone, L Beccaria, et al.
Histopathology|January 14, 2004
Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancersA M Groeger, V Esposito, A De Luca, et al.
Histopathology|April 22, 2005
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological featuresG Perrone, D Santini, B Vincenzi, et al.
Journal of Clinical Pathology|January 29, 2005
Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinomaD Santini, G Tonini, F M Vecchio, et al.
British Journal of Cancer|October 31, 2008
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?V Catalano, F Graziano, D Santini, et al.
Journal of Clinical Pathology|June 25, 2005
Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancerV Esposito, A Baldi, A De Luca, et al.
European Review for Medical and Pharmacological Sciences|March 7, 2020
Pheromone receptors and their putative ligands: possible role in humansV Precone, S Paolacci, T Beccari, et al.
Pageof 22